Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Joe Donato who wrote (1118)	5/21/1999 12:03:00 PM
From: my2boys	Read Replies (2) \| Respond to of 1754

"o Developments in patent litigation in which we are a defendant, particularly to the extent that adverse developments in these proceedings render certain of our patents invalid or unenforceable, which would reduce the scope of proprietary protection available to us and could limit our ability to collect license fees from sellers and users of laser vision correction equipment, which could have a material adverse effect on our business, financial condition and results of operations;" Is this filing recent? Do we have a time frame for this issue to be resolved?

To: Joe Donato who wrote (1118)	5/21/1999 8:50:00 PM
From: capitalistbeatnik	Read Replies (2) \| Respond to of 1754

The upcoming FTC ruling has nothing to do with the fees which are perfectly legal. These posts suggest that VISX may not be able to collect fees next week if something happens and that is far from the truth. VISX will be able to continue to collect until 2006 no matter what. I suggest if people don't do their due diligence to understand this issue, review the last conference call when this was discussed at length, then avoid this stock because it requires a little effort to get it straight in which case you will relax. See Bloomberg post below.